This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Abbvie Inc.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Evelyn M McKeegan
Introduction
Evelyn M McKeegan is a notable inventor based in Lake Forest, IL (US). She has made significant contributions to the field of cancer therapy through her innovative research and patent work. Her dedication to improving patient outcomes is evident in her patented methods for identifying patient classes.
Latest Patents
Evelyn holds a patent for "Biomarkers for identifying patient classes." This patent discloses methods for classifying a patient with cancer as a candidate for therapy with a Bcl-2 family inhibitor. The process involves determining the level of at least one biomarker in a sample and comparing it to a threshold level. Additionally, the patent describes methods for identifying classes of patients with refractory cancer for second-line therapy using a Bcl-2 family inhibitor.
Career Highlights
Evelyn is currently employed at AbbVie Inc., where she continues to work on innovative solutions in the healthcare sector. Her research focuses on enhancing the effectiveness of cancer treatments through biomarker identification.
Collaborations
Evelyn has collaborated with esteemed colleagues, including Barry Lee Dowell and Richard R Lesniewski, to advance her research and patent initiatives.
Conclusion
Evelyn M McKeegan's contributions to cancer therapy through her innovative patents and collaborative efforts highlight her commitment to improving patient care. Her work exemplifies the impact of research and innovation in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile